Literature DB >> 31342659

Changes in oral microbial profiles associated with oral squamous cell carcinoma vs leukoplakia.

Kengo Hashimoto1, Dai Shimizu2, Sho Hirabayashi2, Sei Ueda1, Satoru Miyabe1, Ichiro Oh-Iwa3, Toru Nagao1, Kazuo Shimozato1, Shuji Nomoto2.   

Abstract

AIM: Oral squamous cell carcinoma (OSCC) is the most frequently occurring cancer among head and neck SCC worldwide. The identification of novel effective biomarkers for early detection may greatly improve the survival rate and prognosis of patients with OSCC. This study aimed to identify specific oral microbial profiles associated with OSCC.
METHODS: Saliva samples were collected from oral leukoplakia (OLK) and OSCC patients (N = 6 each) and healthy controls (HC; N = 4). Total bacterial genomic DNA was isolated and 16S rRNA gene survey was performed by next-generation sequencing of the V4 region. The relative distribution of abundance for phylogenetic groups was compared among the OSCC and OLK groups.
RESULTS: The 448 operational taxonomic units detected from the libraries were classified into 133 genera, 69 families, 41 orders, 26 classes and 12 phyla. The abundance of phyla Bacteroidetes and genus Solobacterium was notably higher in the OSCC group when compared with the OLK group, whereas those of genus Streptococcus was significantly lower in the OSCC group when compared with the OLK.
CONCLUSION: These changes in the salivary microbiome may have potential applications as a novel diagnostic tool for the early detection of OSCC.
© 2019 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  bacterial 16S rRNA; oral leukoplakia; oral microbiome; oral squamous cell carcinoma; saliva

Mesh:

Substances:

Year:  2019        PMID: 31342659     DOI: 10.1111/jicd.12445

Source DB:  PubMed          Journal:  J Investig Clin Dent        ISSN: 2041-1618


  5 in total

1.  Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.

Authors:  Avdhesh Kumar Rai; Madhusmita Panda; Ashok Kumar Das; Tashnin Rahman; Rajjyoti Das; Kishore Das; Anupam Sarma; Amal Ch Kataki; Indranil Chattopadhyay
Journal:  Arch Microbiol       Date:  2020-08-11       Impact factor: 2.552

2.  Microbiome and oral squamous cell carcinoma: a possible interplay on iron metabolism and its impact on tumor microenvironment.

Authors:  Rodrigo Alex Arthur; Rafael Dos Santos Bezerra; João Paulo Bianchi Ximenez; Bruna Laís Merlin; Raphael de Andrade Morraye; João Valentini Neto; Natália Melo Nasser Fava; David Livingstone Alves Figueiredo; Carlos Alberto Oliveira de Biagi; Maria Jara Montibeller; Jhefferson Barbosa Guimarães; Ellen Gomes Alves; Monique Schreiner; Tiago Silva da Costa; Charlie Felipe Liberati da Silva; Jessica Moraes Malheiros; Luan Henrique Burda da Silva; Guilherme Taborda Ribas; Daisy Obispo Achallma; Camila Margalho Braga; Karen Flaviane Assis Andrade; Valquiria do Carmo Alves Martins; Glauco Vinícius Nestor Dos Santos; Caroline Fabiane Granatto; Ulisses Costa Terin; Igor Henrique Sanches; Diana Estefania Ramos; Humberto Miguel Garay-Malpartida; Gabriela Marcelino Pereira de Souza; Svetoslav Nanev Slavov; Wilson Araújo Silva
Journal:  Braz J Microbiol       Date:  2021-05-18       Impact factor: 2.476

3.  Optimizing the quality of clinical studies on oral microbiome: A practical guide for planning, performing, and reporting.

Authors:  Egija Zaura; Vincent Y Pappalardo; Mark J Buijs; Catherine M C Volgenant; Bernd W Brandt
Journal:  Periodontol 2000       Date:  2020-11-23       Impact factor: 7.589

Review 4.  Oral Microbiota-A New Frontier in the Pathogenesis and Management of Head and Neck Cancers.

Authors:  Marjut Metsäniitty; Shrabon Hasnat; Tuula Salo; Abdelhakim Salem
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

Review 5.  Crosstalk between the oral microbiota, mucosal immunity, and the epithelial barrier regulates oral mucosal disease pathogenesis.

Authors:  Dongjia Lin; Lisa Yang; Liling Wen; Huanzi Lu; Qianming Chen; Zhi Wang
Journal:  Mucosal Immunol       Date:  2021-05-26       Impact factor: 7.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.